Format
Sort by
Items per page

Send to

Choose Destination

Best matches for parkinson's disease circadian:

Sleep and circadian rhythm regulation in early Parkinson disease. Breen DP et al. JAMA Neurol. (2014)

[Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches]. Faludi B et al. Orv Hetil. (2015)

Circadian and sleep disorders in Parkinson's disease. Videnovic A et al. Exp Neurol. (2013)

Search results

Items: 1 to 20 of 468

1.

[Circadian changes in the structure of cardiac rhythm during pre-symptomatic and symptomatic stages of Parkinson's disease].

Mamalyga ML, Mamalyga LM.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8):85-90. doi: 10.17116/jnevro201811808185. Russian.

PMID:
30251984
2.

Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson's disease.

Ortuño-Lizarán I, Esquiva G, Beach TG, Serrano GE, Adler CH, Lax P, Cuenca N.

Acta Neuropathol Commun. 2018 Sep 10;6(1):90. doi: 10.1186/s40478-018-0596-z.

3.

Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis.

Ishii T, Warabi E, Mann GE.

Free Radic Biol Med. 2018 Sep 4. pii: S0891-5849(18)31523-5. doi: 10.1016/j.freeradbiomed.2018.09.002. [Epub ahead of print] Review.

PMID:
30189266
4.

Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease.

Choudhury GR, Daadi MM.

PLoS One. 2018 Aug 23;13(8):e0202770. doi: 10.1371/journal.pone.0202770. eCollection 2018.

5.

Abrogation of the Circadian Nuclear Receptor REV-ERBα Exacerbates 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration.

Kim J, Jang S, Choi M, Chung S, Choe Y, Choe HK, Son GH, Rhee K, Kim K.

Mol Cells. 2018 Aug 31;41(8):742-752. doi: 10.14348/molcells.2018.0201. Epub 2018 Jul 30.

6.

Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease.

Milazzo V, Di Stefano C, Vallelonga F, Sobrero G, Zibetti M, Romagnolo A, Merola A, Milan A, Espay AJ, Lopiano L, Veglio F, Maule S.

Parkinsonism Relat Disord. 2018 Jun 28. pii: S1353-8020(18)30300-6. doi: 10.1016/j.parkreldis.2018.06.032. [Epub ahead of print]

PMID:
30057156
7.

Circadian rhythms and influencing factors of xerostomia among Parkinson's disease patients.

Barbe AG, Ludwar L, Scharfenberg I, Hellmich M, Dano R, Barbe MT, Noack MJ.

Oral Dis. 2018 Jul 20. doi: 10.1111/odi.12942. [Epub ahead of print]

PMID:
30028552
8.

Parkinson's Disease: Mitochondria Parked at the ER Hit the Snooze Button.

Woodling NS, Partridge L.

Neuron. 2018 Jun 27;98(6):1059-1061. doi: 10.1016/j.neuron.2018.06.025.

PMID:
29953866
9.

Zinc Exacerbates Tau Pathology in a Tau Mouse Model.

Craven KM, Kochen WR, Hernandez CM, Flinn JM.

J Alzheimers Dis. 2018;64(2):617-630. doi: 10.3233/JAD-180151.

PMID:
29914030
10.

ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson's Disease.

Valadas JS, Esposito G, Vandekerkhove D, Miskiewicz K, Deaulmerie L, Raitano S, Seibler P, Klein C, Verstreken P.

Neuron. 2018 Jun 27;98(6):1155-1169.e6. doi: 10.1016/j.neuron.2018.05.022. Epub 2018 Jun 7.

PMID:
29887339
11.

Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men.

Leng Y, Goldman SM, Cawthon PM, Stone KL, Ancoli-Israel S, Yaffe K.

Int J Epidemiol. 2018 Jun 4. doi: 10.1093/ije/dyy098. [Epub ahead of print]

PMID:
29873737
12.

Impaired Photic Entrainment of Spontaneous Locomotor Activity in Mice Overexpressing Human Mutant α-Synuclein.

Pfeffer M, Zimmermann Z, Gispert S, Auburger G, Korf HW, von Gall C.

Int J Mol Sci. 2018 Jun 3;19(6). pii: E1651. doi: 10.3390/ijms19061651.

13.

Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1-BMAL1 Pathway in 6-OHDA-Induced Models of Parkinson's Disease.

Wang Y, Lv D, Liu W, Li S, Chen J, Shen Y, Wang F, Hu LF, Liu CF.

Oxid Med Cell Longev. 2018 Apr 18;2018:4854732. doi: 10.1155/2018/4854732. eCollection 2018.

14.

Melanopsin-mediated pupil function is impaired in Parkinson's disease.

Joyce DS, Feigl B, Kerr G, Roeder L, Zele AJ.

Sci Rep. 2018 May 17;8(1):7796. doi: 10.1038/s41598-018-26078-0.

15.

Rotigotine Improves Abnormal Circadian Rhythm of Blood Pressure in Parkinson's Disease.

Oka H, Nakahara A, Umehara T.

Eur Neurol. 2018;79(5-6):281-286. doi: 10.1159/000489574. Epub 2018 May 15.

PMID:
29763930
16.

Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis.

Huang Z, Liu Q, Peng Y, Dai J, Xie Y, Chen W, Long S, Pei Z, Su H, Yao X.

Front Neurol. 2018 Apr 24;9:218. doi: 10.3389/fneur.2018.00218. eCollection 2018.

17.

A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.

De Pablo-Fernández E, Courtney R, Warner TT, Holton JL.

JAMA Neurol. 2018 Aug 1;75(8):1008-1012. doi: 10.1001/jamaneurol.2018.0640.

PMID:
29710120
18.

Role of Melatonin in the Inflammatory Process and its Therapeutic Potential.

Carrascal L, Nunez-Abades P, Ayala A, Cano M.

Curr Pharm Des. 2018;24(14):1563-1588. doi: 10.2174/1381612824666180426112832.

PMID:
29701146
19.

Disturbances of Sleep and Alertness in Parkinson's Disease.

Videnovic A.

Curr Neurol Neurosci Rep. 2018 Apr 19;18(6):29. doi: 10.1007/s11910-018-0838-2. Review.

PMID:
29675716
20.

Multidimensional Circadian Monitoring by Wearable Biosensors in Parkinson's Disease.

Madrid-Navarro CJ, Escamilla-Sevilla F, Mínguez-Castellanos A, Campos M, Ruiz-Abellán F, Madrid JA, Rol MA.

Front Neurol. 2018 Mar 26;9:157. doi: 10.3389/fneur.2018.00157. eCollection 2018.

Supplemental Content

Loading ...
Support Center